Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

Leukemia

Volumn 16, Issue 9, 2002, Pages 1713-1724

  Konopleva, M ^a   Konoplev, S ^a   Hu, W ^a   Zaritskey, A Y ^b   Afanasiev, B V ^b   Andreeff, M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

AML; Apoptosis; Bcl 2; Stroma

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; IDARUBICIN; INHIBITOR OF APOPTOSIS PROTEIN; PROTEIN BCL 2; PROTEIN BCL XL; TOPOTECAN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; CANCER PATIENT; CANCER RESISTANCE; CELL INTERACTION; CELL SEPARATION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKEMIA CELL; MALE; MICROENVIRONMENT; MICROPORE FILTER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; STROMA CELL;

EID: 0036738149     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402608     Document Type: Article

References (83)

1. Regulation of hemopoietic cell growth and development: Experimental and clinical studies
2. Regulation of hemopoiesis by bone marrow stromal cells and their products
3. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors
4. Growth and differentiation in the hemopoietic system
5. In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells
6. Murine stromal cell line HESS-5 maintains reconstituting ability of ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood
7. − cells and stroma induces a soluble activity that specifically increases primitive hematopoietic cell production
8. Bone marrow adherent layers inhibit apoptosis of acute myeloid leukemia cells
9. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia
10. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro
11. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5)
12. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome
13. Stromal cells regulate bcl-2 and bax expression in pro-B cells
14. The role of soluble growth factors in inducing transient growth and clonal extinction of stroma cell dependent erythroblastic leukemia cells
15. A novel hematopoietic multilineage clone, Myl-D-7, is stromal cell-dependent and supported by an alternative mechanism(s) independent of stem cell factor/c-kit interaction
16. Reproducible establishment of hemopoietic supportive stromal cell lines from murine bone marrow
17. − progenitor cells in long-term cultures and semisolid assays
18. A combination of stem cell factor and granulocyte colony-stimulating factor enhances the growth of human progenitor B cells supported by murine stromal cell line MS-5
19. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in nonswitched long-term culture on murine stroma
20. A murine stromal cell fine promotes the proliferation of the human factor-dependent leukemic cell line UT-7
21. − progenitor cells from human cord blood generate B lymphocytes and granulocytes
22. Characterization and retroviral transduction of an early human lymphomyeloid precursor assayed in nonswitched long-term culture on murine stroma
23. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
24. Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA
25. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
26. Stable cell membrane labelling
27. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis
28. Development of clinical standards for flow cytometry
29. Leukemia associated changes identified by quantitative flow cytometry: I. CD10 expression
30. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
31. Comparative Ct method. ABI Prism 7700 Sequence Detection System
32. Hematopoietic-promoting activity of the murine stromal cell line MS-5 is not related to the expression of the major hematopoietic cytokines
33. In vitro long-term culture of human primitive hematopoietic cells supported by murine stromal cell line MS-5
34. The Mpl-ligand is involved in the growth-promoting activity of the murine stromal cell line MS-5 on ES cell-derived hematopoiesis
35. Characterization of murine hemopoietic-supportive (MS1 and MS-5) and non-supportive (MS-K) cell lines
36. Hepatocyte growth factor as a hematopoietic regulator
37. Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms
38. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion
39. Steel factor and c-kit regulate cell-matrix adhesion
40. Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells
41. Betaglycan presents ligand to the TGF beta signaling receptor
42. Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface
43. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)
44. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
45. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
46. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
47. + hematopoietic progenitor cells
48. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1
49. Phorbol esters and SDF-1 induce rapid endocytosis and down modulation of the chemokine receptor CXCR4
50. Downregulation of c-kit (stem cell factor receptor) in transformed hematopoietic precursor cells by stroma cells
51. Leukemia milieu differentiates bone marrow mesenchymal stem cells into stromal-like cells that support leukemia cell survival
52. Enzymatic treatment of long-term human marrow cultures reveals the preferential location of primitive hemopoietic progenitors in the adherent layer
53. Conditions controlling the proliferation of hemopoietic stem cells in vitro
54. Characterization and partial purification of human marrow cells capable of initiating long-term hematopoiesis in vitro
55. Purified primitive human hematopoietic progenitor cells with long-term in vitro repopulating capacity adhere selectively to irradiated bone marrow stroma
56. Interaction of acute leukemia cells with the bone marrow microenvironment: Implications for control of minimal residual disease
57. Bone marrow stromal cells attenuate mitoxantrone cytotoxicity against HL-60 leukemic cells
58. Bcl-2 modulation of apoptosis induced by anticancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways
59. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
60. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
61. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines
62. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
63. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells
64. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
65. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia
66. The relationship between bcl-2 expression and response to chemotherpay in acute leukaemia
67. Bcl-2 protein expression in normal human bone marrow precursors and in acute myelogenous leukemia
68. Induction of bcl-2 gene expression by intercellular information from hemopoietic supportive stromal cells to DA-1 cells
69. Diminished cell proliferation associated with the death-protective activity of Bcl-2
70. Regulation of cell division cycle progression by bcl-2 expression: A potential mechanism for inhibition of programmed cell death
71. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation
72. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry
73. Effect of direct cell-to-cell interaction between the KM-102 clonal human marrow stromal cell line and the HL-60 myeloid leukemic cell line on the differentiation and proliferation of the HL-60 line
74. Differentiation induction of HL-60 cells in a long-term bone marrow culture of acute myeloid leukemia
75. Overexpression of antiapoptotic Bcl-XL and Bcl-2 contributes to chemoresistance of quiescent leukemic progenitors and can be selectively reversed by ATRA
76. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: Involvement of free radicals
77. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells
78. Phosphorylation of BCL-2 after exposure of human leukemic cells to retinoic acid
79. Effects of BCL-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells
80. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C
81. Inhibition of Bcl-2 with liposomal-delivered antisense oligonucleotides (AS-ODN) induces apoptosis and increases the sensitivity of primary acute myeloid leukemia (AML) cells and cell lines to cytosine arabinoside and doxorubicin
82. Induction of apoptosis in AML by HA14-1: A cell-permeable organic compound identified by protein structure-based computer screening that binds the BH1 to BH3 surface pocket of Bcl-2
83. Phase I trial of Genasense™ (G3139, Genta, Inc), a bcl-2 antisense (AS), in refractory (REF) or relapsed (REL) acute leukemia (AL)